
{"id":7169,"date":"2021-09-08T10:08:49","date_gmt":"2021-09-08T15:08:49","guid":{"rendered":"https:\/\/clinvest-research2021.local\/press-release-clinvest-research-gets-fresh-focus-under-new-ownership\/"},"modified":"2023-08-02T10:11:33","modified_gmt":"2023-08-02T15:11:33","slug":"clinvest-research-gets-fresh-focus-under-new-ownership","status":"publish","type":"post","link":"https:\/\/clinvest.com\/es\/clinvest-research-gets-fresh-focus-under-new-ownership\/","title":{"rendered":"Clinvest Research Gets Fresh Focus Under New Ownership"},"content":{"rendered":"<h3>Clinvest Research Gets Fresh Focus Under New Ownership<\/h3>\n<p><img decoding=\"async\" class=\"wp-image-7852 alignleft lazyload\" data-src=\"https:\/\/clinvest.com\/wp-content\/uploads\/2022\/10\/Ryan-300x300.png\" alt=\"\" width=\"261\" height=\"261\" data-srcset=\"https:\/\/clinvest.com\/wp-content\/uploads\/2022\/10\/Ryan-300x300.png 300w, https:\/\/clinvest.com\/wp-content\/uploads\/2022\/10\/Ryan-150x150.png 150w, https:\/\/clinvest.com\/wp-content\/uploads\/2022\/10\/Ryan-12x12.png 12w, https:\/\/clinvest.com\/wp-content\/uploads\/2022\/10\/Ryan.png 472w\" data-sizes=\"(max-width: 261px) 100vw, 261px\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" style=\"--smush-placeholder-width: 261px; --smush-placeholder-aspect-ratio: 261\/261;\" \/><\/p>\n<p>The development of new therapeutic drugs takes years of research and clinical trials. This fact is not surprising, but what may surprise people is that many of those treatments are tested right here in Springfield. What was founded as a small headache clinic by Dr. Roger Cady in 1996 has grown into a nationwide leader in clinical research now under the ownership and direction of his son Ryan Cady.<\/p>\n<p>Ryan has been involved in clinical research for more than a decade, and has a strong commitment to the continued success of Clinvest Research. Over the years Clinvest Research, together with its sister clinic Headache Care Center, focused much of its effort on advancing treatment of head pain. This commitment to headache research will continue through a strong partnership with the now-independent Headache Care Center. However, Ryan Cady\u2019s vision goes well beyond that of headaches.<\/p>\n<p>By working with a team of local physicians, Clinvest plans to provide patients with access to some of the newest research in multiple areas, including migraine, Alzheimer\u2019s, fibromyalgia, arthritis and cluster headache. Over the coming months their goal is to expand therapeutic reach to include additional disease states while continuing their commitment to excellence in research.<\/p>\n<p>Says Ryan Cady, \u201cWe are thankful to be part of these cutting edge research studies and are excited to offer unique opportunities to advance medicine to those living in the Ozarks.\u201d<\/p>\n<h3>Acerca de Clinvest Research<\/h3>\n<p>Clinvest es una organizaci\u00f3n de investigaci\u00f3n dedicada al avance de la medicina y gesti\u00f3n de la salud a trav\u00e9s de la investigaci\u00f3n cl\u00ednica, fue fundada por el Dr. Roger Cady en 1996. Clinvest comenz\u00f3 como una oficina de investigaci\u00f3n asociada a una peque\u00f1a cl\u00ednica independiente de atenci\u00f3n primaria especializada en dolores de cabeza, situada en Springfield, Missouri.\n\nDr. Cady\u2019s vision was to explore concepts sparked by information gathered in a clinical setting. Combining his clinical expertise in headache and his understanding of the value of patient reporting, Clinvest was formed. The results of many of those early migraine trials have revolutionized our understanding and treatment of migraine today.<\/p>\n<p>Clinvest es un centro de investigaci\u00f3n m\u00e9dica dedicado y apasionado por los nuevos conceptos de control y prevenci\u00f3n de enfermedades. Trabajamos con algunos de los mejores especialistas en dolores de cabeza del pa\u00eds, as\u00ed como con otros m\u00e9dicos especialistas situados en el \u00e1rea de Springfield, Missouri. \n\nLlevamos a cabo la investigaci\u00f3n de fase II-IV de la Administraci\u00f3n de Medicamentos y Alimentos (FDA, por sus siglas en ingl\u00e9s) en nuestras instalaciones de \u00faltima generaci\u00f3n, convenientemente situadas. La mayor\u00eda de los estudios de investigaci\u00f3n llevados a cabo en Clinvest son multic\u00e9ntricos nacionales o mundiales en los que participan entre cientos y miles de personas. \n\nNuestro dedicado equipo de profesionales de investigaci\u00f3n est\u00e1 comprometido con la excelencia, lo que nos convierte en l\u00edderes en el campo de la Investigaci\u00f3n Cl\u00ednica. De hecho, Clinvest Clinical Research ha llevado a cabo m\u00e1s de 400 ensayos cl\u00ednicos patrocinados por las principales compa\u00f1\u00edas farmac\u00e9uticas mundiales en una serie de \u00e1reas de investigaci\u00f3n que incluyen dolores de cabeza, hipertensi\u00f3n, diabetes, osteoartritis, trastornos gastrointestinales, Alzheimer, fibromialgia, herpes simple, asma, dolor lumbar, biomarcadores inflamatorios y la hiperlipidemia.<\/p>","protected":false},"excerpt":{"rendered":"<p>The development of new therapeutic drugs takes years of research and clinical trials. This fact is not surprising, but what may surprise people is that many of those treatments are tested right here in Springfield. What was founded as a small headache clinic by Dr. Roger Cady in 1996 has grown into a nationwide leader in clinical research now under the ownership and direction of his son Ryan Cady.<\/p>\n<p>Ryan has been involved in clinical research for more than a decade, and has a strong commitment to the continued success of Clinvest Research. Over the years Clinvest Research, together with its sister clinic Headache Care Center, focused much of its effort on advancing treatment of head pain. This commitment to headache research will continue through a strong partnership with the now-independent Headache Care Center. However, Ryan Cady\u2019s vision goes well beyond that of headaches.<\/p>\n<p>By working with a team of local physicians, Clinvest plans to provide patients with access to some of the newest research in multiple areas, including migraine, Alzheimer\u2019s, fibromyalgia, arthritis and cluster headache. Over the coming months their goal is to expand therapeutic reach to include additional disease states while continuing their commitment to excellence in research.<\/p>\n<p>Says Ryan Cady, \u201cWe are thankful to be part of these cutting edge research studies and are excited to offer unique opportunities to advance medicine to those living in the Ozarks.\u201d<\/p>","protected":false},"author":1,"featured_media":7852,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[10],"tags":[11],"class_list":["post-7169","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-staff","tag-clinical-researchclinical-trialclinvest-research"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clinvest Research Gets Fresh Focus Under New Ownership - Clinvest Research<\/title>\n<meta name=\"description\" content=\"Clinvest Research gets fresh focus under new ownership and is now under the ownership and direction of Ryan Cady.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/clinvest.com\/es\/clinvest-research-gets-fresh-focus-under-new-ownership\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinvest Research Gets Fresh Focus Under New Ownership - Clinvest Research\" \/>\n<meta property=\"og:description\" content=\"Clinvest Research gets fresh focus under new ownership and is now under the ownership and direction of Ryan Cady.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/clinvest.com\/es\/clinvest-research-gets-fresh-focus-under-new-ownership\/\" \/>\n<meta property=\"og:site_name\" content=\"Clinvest Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ClinvestResearch\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-08T15:08:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-02T15:11:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/clinvest.com\/wp-content\/uploads\/2022\/10\/Ryan.png\" \/>\n\t<meta property=\"og:image:width\" content=\"472\" \/>\n\t<meta property=\"og:image:height\" content=\"472\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"frankandmaven\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Clinvest417\" \/>\n<meta name=\"twitter:site\" content=\"@Clinvest417\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"frankandmaven\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/clinvest.com\\\/clinvest-research-gets-fresh-focus-under-new-ownership\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/clinvest.com\\\/clinvest-research-gets-fresh-focus-under-new-ownership\\\/\"},\"author\":{\"name\":\"frankandmaven\",\"@id\":\"https:\\\/\\\/clinvest.com\\\/#\\\/schema\\\/person\\\/2212291c701cc5bea6397518631c3993\"},\"headline\":\"Clinvest Research Gets Fresh Focus Under New Ownership\",\"datePublished\":\"2021-09-08T15:08:49+00:00\",\"dateModified\":\"2023-08-02T15:11:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/clinvest.com\\\/clinvest-research-gets-fresh-focus-under-new-ownership\\\/\"},\"wordCount\":481,\"publisher\":{\"@id\":\"https:\\\/\\\/clinvest.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/clinvest.com\\\/clinvest-research-gets-fresh-focus-under-new-ownership\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/clinvest.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/Ryan.png\",\"keywords\":[\"Clinical Research|Clinical Trial|Clinvest Research\"],\"articleSection\":[\"Staff\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/clinvest.com\\\/clinvest-research-gets-fresh-focus-under-new-ownership\\\/\",\"url\":\"https:\\\/\\\/clinvest.com\\\/clinvest-research-gets-fresh-focus-under-new-ownership\\\/\",\"name\":\"Clinvest Research Gets Fresh Focus Under New Ownership - Clinvest Research\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/clinvest.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/clinvest.com\\\/clinvest-research-gets-fresh-focus-under-new-ownership\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/clinvest.com\\\/clinvest-research-gets-fresh-focus-under-new-ownership\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/clinvest.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/Ryan.png\",\"datePublished\":\"2021-09-08T15:08:49+00:00\",\"dateModified\":\"2023-08-02T15:11:33+00:00\",\"description\":\"Clinvest Research gets fresh focus under new ownership and is now under the ownership and direction of Ryan Cady.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/clinvest.com\\\/clinvest-research-gets-fresh-focus-under-new-ownership\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/clinvest.com\\\/clinvest-research-gets-fresh-focus-under-new-ownership\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/clinvest.com\\\/clinvest-research-gets-fresh-focus-under-new-ownership\\\/#primaryimage\",\"url\":\"https:\\\/\\\/clinvest.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/Ryan.png\",\"contentUrl\":\"https:\\\/\\\/clinvest.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/Ryan.png\",\"width\":472,\"height\":472,\"caption\":\"Clinvest Research Gets Fresh Focus Under New Ownership\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/clinvest.com\\\/clinvest-research-gets-fresh-focus-under-new-ownership\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/clinvest.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clinvest Research Gets Fresh Focus Under New Ownership\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/clinvest.com\\\/#website\",\"url\":\"https:\\\/\\\/clinvest.com\\\/\",\"name\":\"Clinvest Research\",\"description\":\"Clinical Research in Springfield, MO\",\"publisher\":{\"@id\":\"https:\\\/\\\/clinvest.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/clinvest.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/clinvest.com\\\/#organization\",\"name\":\"Clinvest Research\",\"url\":\"https:\\\/\\\/clinvest.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/clinvest.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/clinvest.com\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/clinvest_plain_logo.png\",\"contentUrl\":\"https:\\\/\\\/clinvest.com\\\/wp-content\\\/uploads\\\/2021\\\/08\\\/clinvest_plain_logo.png\",\"width\":956,\"height\":295,\"caption\":\"Clinvest Research\"},\"image\":{\"@id\":\"https:\\\/\\\/clinvest.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ClinvestResearch\\\/\",\"https:\\\/\\\/x.com\\\/Clinvest417\",\"https:\\\/\\\/www.instagram.com\\\/clinvest417\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/clinvest-research-llc.\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/clinvest.com\\\/#\\\/schema\\\/person\\\/2212291c701cc5bea6397518631c3993\",\"name\":\"frankandmaven\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bc6c6cb5ae3e8839acf66ca0841d12b1256684e68a389d97dab0cb57b45674b4?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bc6c6cb5ae3e8839acf66ca0841d12b1256684e68a389d97dab0cb57b45674b4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bc6c6cb5ae3e8839acf66ca0841d12b1256684e68a389d97dab0cb57b45674b4?s=96&d=mm&r=g\",\"caption\":\"frankandmaven\"},\"sameAs\":[\"http:\\\/\\\/clinvestresearch.flywheelsites.com\"],\"url\":\"https:\\\/\\\/clinvest.com\\\/es\\\/author\\\/frankandmaven\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinvest Research Gets Fresh Focus Under New Ownership - Clinvest Research","description":"Clinvest Research gets fresh focus under new ownership and is now under the ownership and direction of Ryan Cady.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/clinvest.com\/es\/clinvest-research-gets-fresh-focus-under-new-ownership\/","og_locale":"es_MX","og_type":"article","og_title":"Clinvest Research Gets Fresh Focus Under New Ownership - Clinvest Research","og_description":"Clinvest Research gets fresh focus under new ownership and is now under the ownership and direction of Ryan Cady.","og_url":"https:\/\/clinvest.com\/es\/clinvest-research-gets-fresh-focus-under-new-ownership\/","og_site_name":"Clinvest Research","article_publisher":"https:\/\/www.facebook.com\/ClinvestResearch\/","article_published_time":"2021-09-08T15:08:49+00:00","article_modified_time":"2023-08-02T15:11:33+00:00","og_image":[{"width":472,"height":472,"url":"https:\/\/clinvest.com\/wp-content\/uploads\/2022\/10\/Ryan.png","type":"image\/png"}],"author":"frankandmaven","twitter_card":"summary_large_image","twitter_creator":"@Clinvest417","twitter_site":"@Clinvest417","twitter_misc":{"Escrito por":"frankandmaven","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/clinvest.com\/clinvest-research-gets-fresh-focus-under-new-ownership\/#article","isPartOf":{"@id":"https:\/\/clinvest.com\/clinvest-research-gets-fresh-focus-under-new-ownership\/"},"author":{"name":"frankandmaven","@id":"https:\/\/clinvest.com\/#\/schema\/person\/2212291c701cc5bea6397518631c3993"},"headline":"Clinvest Research Gets Fresh Focus Under New Ownership","datePublished":"2021-09-08T15:08:49+00:00","dateModified":"2023-08-02T15:11:33+00:00","mainEntityOfPage":{"@id":"https:\/\/clinvest.com\/clinvest-research-gets-fresh-focus-under-new-ownership\/"},"wordCount":481,"publisher":{"@id":"https:\/\/clinvest.com\/#organization"},"image":{"@id":"https:\/\/clinvest.com\/clinvest-research-gets-fresh-focus-under-new-ownership\/#primaryimage"},"thumbnailUrl":"https:\/\/clinvest.com\/wp-content\/uploads\/2022\/10\/Ryan.png","keywords":["Clinical Research|Clinical Trial|Clinvest Research"],"articleSection":["Staff"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/clinvest.com\/clinvest-research-gets-fresh-focus-under-new-ownership\/","url":"https:\/\/clinvest.com\/clinvest-research-gets-fresh-focus-under-new-ownership\/","name":"Clinvest Research Gets Fresh Focus Under New Ownership - Clinvest Research","isPartOf":{"@id":"https:\/\/clinvest.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/clinvest.com\/clinvest-research-gets-fresh-focus-under-new-ownership\/#primaryimage"},"image":{"@id":"https:\/\/clinvest.com\/clinvest-research-gets-fresh-focus-under-new-ownership\/#primaryimage"},"thumbnailUrl":"https:\/\/clinvest.com\/wp-content\/uploads\/2022\/10\/Ryan.png","datePublished":"2021-09-08T15:08:49+00:00","dateModified":"2023-08-02T15:11:33+00:00","description":"Clinvest Research gets fresh focus under new ownership and is now under the ownership and direction of Ryan Cady.","breadcrumb":{"@id":"https:\/\/clinvest.com\/clinvest-research-gets-fresh-focus-under-new-ownership\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/clinvest.com\/clinvest-research-gets-fresh-focus-under-new-ownership\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/clinvest.com\/clinvest-research-gets-fresh-focus-under-new-ownership\/#primaryimage","url":"https:\/\/clinvest.com\/wp-content\/uploads\/2022\/10\/Ryan.png","contentUrl":"https:\/\/clinvest.com\/wp-content\/uploads\/2022\/10\/Ryan.png","width":472,"height":472,"caption":"Clinvest Research Gets Fresh Focus Under New Ownership"},{"@type":"BreadcrumbList","@id":"https:\/\/clinvest.com\/clinvest-research-gets-fresh-focus-under-new-ownership\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/clinvest.com\/"},{"@type":"ListItem","position":2,"name":"Clinvest Research Gets Fresh Focus Under New Ownership"}]},{"@type":"WebSite","@id":"https:\/\/clinvest.com\/#website","url":"https:\/\/clinvest.com\/","name":"Clinvest Research","description":"Clinical Research in Springfield, MO","publisher":{"@id":"https:\/\/clinvest.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/clinvest.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/clinvest.com\/#organization","name":"Clinvest Research","url":"https:\/\/clinvest.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/clinvest.com\/#\/schema\/logo\/image\/","url":"https:\/\/clinvest.com\/wp-content\/uploads\/2021\/08\/clinvest_plain_logo.png","contentUrl":"https:\/\/clinvest.com\/wp-content\/uploads\/2021\/08\/clinvest_plain_logo.png","width":956,"height":295,"caption":"Clinvest Research"},"image":{"@id":"https:\/\/clinvest.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ClinvestResearch\/","https:\/\/x.com\/Clinvest417","https:\/\/www.instagram.com\/clinvest417","https:\/\/www.linkedin.com\/company\/clinvest-research-llc."]},{"@type":"Person","@id":"https:\/\/clinvest.com\/#\/schema\/person\/2212291c701cc5bea6397518631c3993","name":"frankandmaven","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/bc6c6cb5ae3e8839acf66ca0841d12b1256684e68a389d97dab0cb57b45674b4?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bc6c6cb5ae3e8839acf66ca0841d12b1256684e68a389d97dab0cb57b45674b4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bc6c6cb5ae3e8839acf66ca0841d12b1256684e68a389d97dab0cb57b45674b4?s=96&d=mm&r=g","caption":"frankandmaven"},"sameAs":["http:\/\/clinvestresearch.flywheelsites.com"],"url":"https:\/\/clinvest.com\/es\/author\/frankandmaven\/"}]}},"_links":{"self":[{"href":"https:\/\/clinvest.com\/es\/wp-json\/wp\/v2\/posts\/7169","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clinvest.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinvest.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinvest.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/clinvest.com\/es\/wp-json\/wp\/v2\/comments?post=7169"}],"version-history":[{"count":3,"href":"https:\/\/clinvest.com\/es\/wp-json\/wp\/v2\/posts\/7169\/revisions"}],"predecessor-version":[{"id":8151,"href":"https:\/\/clinvest.com\/es\/wp-json\/wp\/v2\/posts\/7169\/revisions\/8151"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinvest.com\/es\/wp-json\/wp\/v2\/media\/7852"}],"wp:attachment":[{"href":"https:\/\/clinvest.com\/es\/wp-json\/wp\/v2\/media?parent=7169"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinvest.com\/es\/wp-json\/wp\/v2\/categories?post=7169"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinvest.com\/es\/wp-json\/wp\/v2\/tags?post=7169"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}